 Home > Active Ingredient News > Drugs Articles > Over 1.3 billion US dollars! Hansen Pharmaceuticals reached another cooperation on siRNA therapy

Over 1.3 billion US dollars! Hansen Pharmaceuticals reached another cooperation on siRNA therapy

 Last Update: 2021-10-19
 Source: Internet
 Author: User

Tags

all makeup world

big penis medicine

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On October 15, Hansen Pharmaceuticals has entered into an exclusive license cooperation agreement with Silence Therapeutics plc.

Screenshot source: reference [1]

RNA interference (RNAi) is a universal mechanism that uses non-coding RNA in living cells to control whether a gene is active and how active it is.

Silence Therapeutics is a biotechnology company dedicated to the development of a new generation of drugs.

According to the announcement, among the three target products of this cooperation, for the first two targets, Hansen Pharmaceuticals will have licenses in China (including Hong Kong, Macau and Taiwan) after completing Phase 1 clinical studies.

Silence Therapeutics will receive an upfront payment of US$16 million from Hansen Pharmaceuticals and will be eligible for up to US$1.

According to the announcement, Hansen Pharmaceuticals believes that with Silence Therapeutics' leading position in the development of siRNA therapy and its decades of scientific and technical experience, they see its mRNAi GOLD™ platform develop and bring better results for patients in China and the world.

Reference

[1] Signed a license agreement with SILENCE THERAPEUTICS.

[1] Signed a license agreement with SILENCE THERAPEUTICS.
Retrieved Oct 15, 2021, from https://www1.
hkexnews.
hk/listedco/listconews/sehk/2021/1015/2021101500016_e.
pdf

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Tirzepatide Lyophilized powder Vial 5mg 10mg 15mg 20mg 30mg customize 99% Purity with third side checking report

CAS No.: 2023788-19-2

Pharmacy Grade

$50-60/UNIT FOB

Wight loss Lyophilized Semaglutide Petide powder CAS 910463-68-2 with 99.9% purity

CAS No.: 910463-68-2

Pharmacy Grade

$140-175/G FOB

High Quality (E,E,E,E)-Squalene CAS NO 111-02-4 GMP ISO9001 EP Pharma grade Manufacture

CAS No.: 111-02-4

EP Pharma grade

$400-405/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

80 20 company(94)

united states logo(227)

ups united states(221)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.